daily oral glp-1 receptor agonist orforglipron for adults with obesity A new option is now part of medicine. FDA approved Foundayo (orforglipron), a once-daily oral GLP-1 agonist, obesity or overweight with at least one weight-related Orforglipron:NEW GLP-1 Pill Approved! (Obesity

Our high-purity powder delivers 500mg per serving to help support glutathione levels when your body's natural production needs additional support

IV therapy is often used to treat dehydration, deliver medications, and provide nutritional support for patients who cannot adequately absorb nutrients through their digestive system

Prioritize high-quality sources: lean meats, fish, eggs, Greek yogurt, and whey protein

Eddie provides specific protein guidance and, when appropriate, integrates targeted peptide therapy to promote lean mass and cellular recovery

Standard insulin syringes marked in units (100 units = 1 mL) allow accurate measurement of small volumes